References
- Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin.58(2), 71–96 (2008).
- Rofstad EK, Wahl A, Brustad T. Radiation sensitivity in vitro of cells isolated from human tumor surgical specimens. Cancer Res.47(1), 106–110 (1987).
- Diener-West M, Earle JD, Fine SL et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch. Ophthalmol.119(7), 969–982 (2001).
- Diener-West M, Earle JD, Fine SL et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch. Ophthalmol.119(7), 951–965 (2001).
- Harwood AR, Lawson VG. Radiation therapy for melanomas of the head and neck. Head Neck Surg.4(6), 468–474 (1982).
- Tsang RW, Liu FF, Wells W, Payne DG. Lentigo maligna of the head and neck. Results of treatment by radiotherapy. Arch. Dermatol.130(8), 1008–1012 (1994).
- Schmid-Wendtner MH, Brunner B, Konz B et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J. Am. Acad. Dermatol.43(3), 477–482 (2000).
- Harwood AR. Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. Int. J. Radiat. Oncol. Biol. Phys.9(7), 1019–1021 (1983).
- Johanson CR, Harwood AR, Cummings BJ, Quirt I. Radiotherapy in nodular melanoma. Cancer51(2), 226–232 (1983).
- Creagan ET, Cupps RE, Ivins JC et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: a randomized, prospective study. Cancer42(5), 2206–2210 (1978).
- Agrawal S, Kane JM, Guadagnolo B, Kraybill WG, Ballo M. Therapeutic lymphadenectomy alone versus adjuvant radiotherapy for regional nodal metastases from melanoma. J. Clin. Oncol.26 (2008) (Abstract 9038).
- Overgaard J, von der Maase H, Overgaard M. A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma. Int. J. Radiat. Oncol. Biol. Phys.11(10), 1837–1839 (1985).
- Sause WT, Cooper JS, Rush S et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int. J. Radiat. Oncol. Biol. Phys.20(3), 429–432 (1991).
- Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer110(8), 1791–1795 (2007).
- Meier S, Baumert BG, Maier T et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie27(2), 145–149 (2004).
- Patchell RA, Tibbs PA, Walsh JW et al. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med.322(8), 494–500 (1990).
- Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet363(9422), 1665–1672 (2004).
- Perez DG, Suman VJ, Amatruda Tet al. Phase II trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma. J. Clin Oncol.2007 ASCO Annual Meeting Proceedings25(Suppl. 18) (2007) (Abstract 8560).